Trading Ideas

(Bloomberg) — Moderna Inc. executives have been continuing a slow unwind of their positions — even though a lockup remains in place until Thursday.After a $1.3 billion share sale in May, the vaccine developer’s second cash raise this year, early investors and Moderna management were once again restricted from selling shares. On June 18, those insiders will get a fresh chance to cash in on Moderna’s stratospheric rise, but similar to the prior offering, a handful of the company’s executives have already taken advantage of another way to sell: 10b5-1 trading plans.The plans let insiders trade their shares at predetermined …read more […]

Amana Mutual Funds Trust recently released its Q1 2020 Investor Letter, a copy of which you can download here. The Amana Income Fund posted a return of -18.01% for the quarter, outperforming its benchmark, the S&P 500 Index which returned -19.60% in the same quarter. You should check out Amana Mutual Fund’s top 5 stock […] …read more […]

…read more […]

It’s likely to be a long, hot summer for investors in the stock market says this veteran strategist. …read more […]

Last week, Hertz won bankruptcy court approval to sell up to $1 billion in stock. Clayton did not elaborate on what the issues were with Hertz’s plan, but indicated that the company was unlikely to go through with the offering until those issues were resolved, according to CNBC. Hertz has warned that its shares would be eventually “worthless”, but the stock sale could benefit creditors seeking to recover more of their claims during the bankruptcy process. …read more […]

McDonald’s dividend history is long, but is it safe going forward?
The company has raised and paid its dividend for the last 45 years. This consistency is great for investors and it almost makes McDonald’s an elite dividend king. The kings are companies that have increased dividend payments for 50 consecutive years or more.
To see if McDonald’s will keep on paying a dividend, let’s dig into the business and recent dividend trends. Also, if you’re interested in the company’s response to more recent events, check out our article on McDonald’s stock.
Business Overview and Highlights
McDonald’s is a $139 billion dollar business. The …read more […]

…read more […]

Last week was grim for the stock market, including the worst single-day loss since March, but the trend lines are turning upwards again this week. Treasury Secretary Mnuchin’s statement that the US cannot shut down its economy again gave investors a boost of confidence – and this week’s May retail sales report gave an even bigger one.This is the good news background lending credence a recent report from Morgan Stanley, on finding the advantageous tech position for a V-shaped recovery. The report, lead-authored by 5-star analyst Joseph Moore, details the strengths and weaknesses of the tech sector as companies respond …read more […]

Qatar Airways will not take any new planes ordered from Boeing or Airbus in 2020 or 2021, chief executive Akbar al-Baker said on Wednesday, adding there would be a knock-on effect to future deliveries due to the COVID-19 pandemic. Qatar Airways has ordered tens of billions of dollars of aircraft from the world’s two biggest planemakers. …read more […]

Amana Mutual Funds Trust recently released its Q1 2020 Investor Letter, a copy of which you can download here. The Amana Income Fund posted a return of -18.01% for the quarter, outperforming its benchmark, the S&P 500 Index which returned -19.60% in the same quarter. You should check out Amana Mutual Fund’s top 5 stock […] …read more […]

Even during economic downturns, one fact remains resolute: pharma stocks represent the ultimate risk/reward plays. Out on Wall Street, the sector has become known for its high volatility. How did it earn this reputation? It comes down to the nature of the industry itself.Unlike companies in other areas of the market, pharma stocks depend less on earnings results, and more on clinical data and regulatory decisions. As the latter determine the trajectory of these stocks, a single piece of good news can act as a catalyst that sends shares skyrocketing.That being said, shares can plummet just as easily should a …read more […]

Amana Mutual Funds Trust recently released its Q1 2020 Investor Letter, a copy of which you can download here. The Amana Income Fund posted a return of -18.01% for the quarter, outperforming its benchmark, the S&P 500 Index which returned -19.60% in the same quarter. You should check out Amana Mutual Fund’s top 5 stock […] …read more […]

Are you one of thousands of investors trying to learn how to invest in dexamethasone stock after the recent COVID-19 breakthrough? If so, you have come to the right place. According to a recent study in the United Kingdom, this generic steroid may be saving lives.
The study was conducted by the University of Oxford to test a range of potential treatments. With over 2,000 patients enrolled and tested, dexamethasone has shown sufficient and encouraging results.

Why Invest in Dexamethasone Stock?
There aren’t many companies that produce dexamethasone. But, it’s important to breakdown the study before going any further. This will help you …read more […]

…read more […]

Shares in Chembio Diagnostics (CEMI) sank 59% after the U.S. Food and Drug Administration revoked the Emergency Use Authorization (EUA) of its DPP (Dual Path Platform) COVID-19 serology test.The stock plunged to $4.10 in pre-market trading after the FDA said that there were performance concerns with the accuracy of Chembio’s SARS-CoV-2 antibody test. The U.S. regulator added that it made the decision to revoke the EUA authorization for the serology test as “benefits no longer outweigh its risks”.“This test generates a higher than expected rate of false results and higher than that reflected in the authorized labeling for the device,” …read more […]